Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum

Akiko Matsubara, Shigeki Sekine, Ryoji Kushima, Reiko Ogawa, Hirokazu Taniguchi, Hitoshi Tsuda, Yae Kanai

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal-type, foveolar-type and pyloric gland adenomas. We analysed the mutations in GNAS, KRAS, BRAF and CTNNB1 and the expressions of mismatch repair (MMR) proteins in 80 gastric and 32 duodenal adenomas with histologically distinct subtypes, as well as in 71 gastric adenocarcinomas. Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas. Fourteen PGAs (41%), two foveolar-type adenomas (9%), five intestinal-type adenomas (9%) and one adenocarcinoma (1%) had KRAS mutations. BRAF mutations were absent in all the adenomas and adenocarcinomas that were examined. CTNNB1 mutations were only found in two intestinal-type adenomas (4%). Notably, 13 of the 14 KRAS-mutated gastric and duodenal PGAs had concurrent GNAS mutations. The loss of the MMR proteins, which is indicative of microsatellite instability, was observed in one PGA (3%), 12 foveolar-type adenomas (52%), one intestinal-type adenoma (2%) and five adenocarcinomas (7%). These observations indicate that each histological subtype of gastric and duodenal adenomas has a distinct genetic background. In particular, the present study identified the frequent presence of activating GNAS mutations, which are often associated with KRAS mutations, as a characteristic genetic feature of PGAs of the stomach and duodenum.

Original languageEnglish
Pages (from-to)579-587
Number of pages9
JournalJournal of Pathology
Volume229
Issue number4
DOIs
Publication statusPublished - 2013 Mar
Externally publishedYes

Fingerprint

Gastric Mucosa
Duodenum
Adenoma
Stomach
Mutation
Prostaglandins A
Adenocarcinoma
DNA Mismatch Repair
Microsatellite Instability
Intestinal Mucosa
Proteins

Keywords

  • GNAS
  • KRAS
  • pyloric gland adenoma
  • stomach, duodenum

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Matsubara, A., Sekine, S., Kushima, R., Ogawa, R., Taniguchi, H., Tsuda, H., & Kanai, Y. (2013). Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. Journal of Pathology, 229(4), 579-587. https://doi.org/10.1002/path.4153

Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. / Matsubara, Akiko; Sekine, Shigeki; Kushima, Ryoji; Ogawa, Reiko; Taniguchi, Hirokazu; Tsuda, Hitoshi; Kanai, Yae.

In: Journal of Pathology, Vol. 229, No. 4, 03.2013, p. 579-587.

Research output: Contribution to journalArticle

Matsubara, A, Sekine, S, Kushima, R, Ogawa, R, Taniguchi, H, Tsuda, H & Kanai, Y 2013, 'Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum', Journal of Pathology, vol. 229, no. 4, pp. 579-587. https://doi.org/10.1002/path.4153
Matsubara A, Sekine S, Kushima R, Ogawa R, Taniguchi H, Tsuda H et al. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. Journal of Pathology. 2013 Mar;229(4):579-587. https://doi.org/10.1002/path.4153
Matsubara, Akiko ; Sekine, Shigeki ; Kushima, Ryoji ; Ogawa, Reiko ; Taniguchi, Hirokazu ; Tsuda, Hitoshi ; Kanai, Yae. / Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum. In: Journal of Pathology. 2013 ; Vol. 229, No. 4. pp. 579-587.
@article{8869844bdd6e48a98999e47f683a64f1,
title = "Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum",
abstract = "Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal-type, foveolar-type and pyloric gland adenomas. We analysed the mutations in GNAS, KRAS, BRAF and CTNNB1 and the expressions of mismatch repair (MMR) proteins in 80 gastric and 32 duodenal adenomas with histologically distinct subtypes, as well as in 71 gastric adenocarcinomas. Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63{\%}) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas. Fourteen PGAs (41{\%}), two foveolar-type adenomas (9{\%}), five intestinal-type adenomas (9{\%}) and one adenocarcinoma (1{\%}) had KRAS mutations. BRAF mutations were absent in all the adenomas and adenocarcinomas that were examined. CTNNB1 mutations were only found in two intestinal-type adenomas (4{\%}). Notably, 13 of the 14 KRAS-mutated gastric and duodenal PGAs had concurrent GNAS mutations. The loss of the MMR proteins, which is indicative of microsatellite instability, was observed in one PGA (3{\%}), 12 foveolar-type adenomas (52{\%}), one intestinal-type adenoma (2{\%}) and five adenocarcinomas (7{\%}). These observations indicate that each histological subtype of gastric and duodenal adenomas has a distinct genetic background. In particular, the present study identified the frequent presence of activating GNAS mutations, which are often associated with KRAS mutations, as a characteristic genetic feature of PGAs of the stomach and duodenum.",
keywords = "GNAS, KRAS, pyloric gland adenoma, stomach, duodenum",
author = "Akiko Matsubara and Shigeki Sekine and Ryoji Kushima and Reiko Ogawa and Hirokazu Taniguchi and Hitoshi Tsuda and Yae Kanai",
year = "2013",
month = "3",
doi = "10.1002/path.4153",
language = "English",
volume = "229",
pages = "579--587",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum

AU - Matsubara, Akiko

AU - Sekine, Shigeki

AU - Kushima, Ryoji

AU - Ogawa, Reiko

AU - Taniguchi, Hirokazu

AU - Tsuda, Hitoshi

AU - Kanai, Yae

PY - 2013/3

Y1 - 2013/3

N2 - Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal-type, foveolar-type and pyloric gland adenomas. We analysed the mutations in GNAS, KRAS, BRAF and CTNNB1 and the expressions of mismatch repair (MMR) proteins in 80 gastric and 32 duodenal adenomas with histologically distinct subtypes, as well as in 71 gastric adenocarcinomas. Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas. Fourteen PGAs (41%), two foveolar-type adenomas (9%), five intestinal-type adenomas (9%) and one adenocarcinoma (1%) had KRAS mutations. BRAF mutations were absent in all the adenomas and adenocarcinomas that were examined. CTNNB1 mutations were only found in two intestinal-type adenomas (4%). Notably, 13 of the 14 KRAS-mutated gastric and duodenal PGAs had concurrent GNAS mutations. The loss of the MMR proteins, which is indicative of microsatellite instability, was observed in one PGA (3%), 12 foveolar-type adenomas (52%), one intestinal-type adenoma (2%) and five adenocarcinomas (7%). These observations indicate that each histological subtype of gastric and duodenal adenomas has a distinct genetic background. In particular, the present study identified the frequent presence of activating GNAS mutations, which are often associated with KRAS mutations, as a characteristic genetic feature of PGAs of the stomach and duodenum.

AB - Gastric and duodenal adenomas exhibit a significant morphological and phenotypical diversity and are classified into intestinal-type, foveolar-type and pyloric gland adenomas. We analysed the mutations in GNAS, KRAS, BRAF and CTNNB1 and the expressions of mismatch repair (MMR) proteins in 80 gastric and 32 duodenal adenomas with histologically distinct subtypes, as well as in 71 gastric adenocarcinomas. Activating GNAS mutations were found in 22 of the 35 pyloric gland adenomas (PGAs; 63%) but in none of the foveolar-type or intestinal-type adenomas or the adenocarcinomas. Fourteen PGAs (41%), two foveolar-type adenomas (9%), five intestinal-type adenomas (9%) and one adenocarcinoma (1%) had KRAS mutations. BRAF mutations were absent in all the adenomas and adenocarcinomas that were examined. CTNNB1 mutations were only found in two intestinal-type adenomas (4%). Notably, 13 of the 14 KRAS-mutated gastric and duodenal PGAs had concurrent GNAS mutations. The loss of the MMR proteins, which is indicative of microsatellite instability, was observed in one PGA (3%), 12 foveolar-type adenomas (52%), one intestinal-type adenoma (2%) and five adenocarcinomas (7%). These observations indicate that each histological subtype of gastric and duodenal adenomas has a distinct genetic background. In particular, the present study identified the frequent presence of activating GNAS mutations, which are often associated with KRAS mutations, as a characteristic genetic feature of PGAs of the stomach and duodenum.

KW - GNAS

KW - KRAS

KW - pyloric gland adenoma

KW - stomach, duodenum

UR - http://www.scopus.com/inward/record.url?scp=84874109101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874109101&partnerID=8YFLogxK

U2 - 10.1002/path.4153

DO - 10.1002/path.4153

M3 - Article

VL - 229

SP - 579

EP - 587

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 4

ER -